Central Nervous System Agents in Medicinal Chemistry
Title:Editorial (Thematic Issue: The Activity of Products from Cnidaria: A Therapeutic Tool in Neurological Diseases - Part 1)
Volume: 15 Issue: 2
Author(s): Gian L. Mariottini
Affiliation:
Export Options
About this article
Cite this article as:
Mariottini L. Gian, Editorial (Thematic Issue: The Activity of Products from Cnidaria: A Therapeutic Tool in Neurological Diseases - Part 1), Central Nervous System Agents in Medicinal Chemistry 2015; 15 (2) . https://dx.doi.org/10.2174/187152491502150525114900
DOI https://dx.doi.org/10.2174/187152491502150525114900 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
35
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Physiological Functions of Presenilins; Beyond γ-Secretase
Current Pharmaceutical Biotechnology Brain Connectivity Studies in Schizophrenia: Unravelling the Effects of Antipsychotics
Current Neuropharmacology Development on PEG-modified Poly (Amino Acid) Copolymeric Micelles for Delivery of Anticancer Drug
Anti-Cancer Agents in Medicinal Chemistry Ubiquitin Enzymes, Ubiquitin and Proteasome Activity in Blood Mononuclear Cells of MCI, Alzheimer and Parkinson Patients
Current Alzheimer Research Single Nucleotide Polymorphism and Serum Levels of VEGFR2 are Associated With Age Related Macular Degeneration
Current Neurovascular Research Efficacy of Group Treatments for Alcohol Use Disorders: A Review
Current Drug Abuse Reviews Recent Advances in Herbal Nanomedicines for Cancer Treatment
Current Molecular Pharmacology The Role of Mitochondrial Impairment in Alzheimer´s Disease Neurodegeneration: The Tau Connection
Current Neuropharmacology Current Clinical Applications of Botulinum Toxin
Current Pharmaceutical Design Meet Our Editorial Board Member
Current Alzheimer Research Neuropsychiatric and General Interactions of Natural and Synthetic Cannabinoids with Drugs of Abuse and Medicines
CNS & Neurological Disorders - Drug Targets Commentary: Histaminergic Drugs Could be Novel Targets for Neuroprotection in CNS Disorders
CNS & Neurological Disorders - Drug Targets Oleocanthal, a Natural anti-Inflammatory Compound in Extra Virgin Olive Oil
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Structural and Functional Relationships Between GSK3α and GSK3β Proteins
Current Biotechnology Editorial [Hot Topic: Targeting Cell Migration - The Next Generation Blockbusters (Guest Editors: Amanda E.I. Proudfoot, Marie Kosco-Vilbois and Zoe Johnson)]
Current Immunology Reviews (Discontinued) Conversion of Benzimidazoles, Imidazothiazoles and Imidazoles into more Potent Central Nervous System Acting Drugs
Central Nervous System Agents in Medicinal Chemistry Radical Scavenging and Antioxidant Capacity of Serotonin
Current Bioactive Compounds Design of Multivalent Ligand Targeting G-Protein-Coupled Receptors
Current Pharmaceutical Design Meet Our Editorial Board Member:
Current Neuropharmacology Bupropion HCL and Sleep in Patients with Depression
Current Psychiatry Reviews